Holdings
VanEck Pharmaceutical ETF
As of Jun 30, 2026, VanEck Pharmaceutical ETF reported 25 positions worth US$875M. Largest: Eli Lilly and Company, Novartis AG and Merck & Company, Inc. What it bought and sold, with each filing.
Holdings
- Part of
- VanEck
- Positions
- 25
- Value as reported
- US$875M
- Holdings as of
- Jun 30, 2026
- Last filed
- Aug 26, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Eli Lilly and Company NYSE:LLY | 148K | US$178M | 20.2% | −113K | Jun 30, 2026 |
| Novartis AG SIX:NOVN | 598K | US$93.4M | 10.6% | −314K | Jun 30, 2026 |
| Merck & Company, Inc. NYSE:MRK | 674K | US$86.6M | 9.8% | −361K | Jun 30, 2026 |
| Novo Nordisk A/S Class B OMXCOP:NOVO_B | 998K | US$47.2M | 5.4% | −648K | Jun 30, 2026 |
| AbbVie Inc. NYSE:ABBV | 160K | US$40.2M | 4.6% | −83,678 | Jun 30, 2026 |
| Pfizer, Inc. NYSE:PFE | 1.65M | US$39.6M | 4.5% | −748K | Jun 30, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 682K | US$39.3M | 4.5% | −299K | Jun 30, 2026 |
| GSK plc LSE:GSK | 1.47M | US$38.9M | 4.4% | −673K | Jun 30, 2026 |
| Johnson & Johnson NYSE:JNJ | 151K | US$38.3M | 4.4% | −77,416 | Jun 30, 2026 |
| AstraZeneca PLC LSE:AZN | 201K | US$38.1M | 4.3% | −85,893 | Jun 30, 2026 |
| McKesson Corporation NYSE:MCK | 47,981 | US$36.3M | 4.1% | −14,971 | Jun 30, 2026 |
| Sanofi SA EURONEXT:SAN | 414K | US$35.2M | 4.0% | −216K | Jun 30, 2026 |
| Cencora, Inc. NYSE:COR | 104K | US$29.5M | 3.4% | −48,660 | Jun 30, 2026 |
| Haleon PLC LSE:HLN | 5.89M | US$27.2M | 3.1% | −2.47M | Jun 30, 2026 |
| Teva Pharmaceutical Industries Limited TASE:TEVA | 794K | US$26.9M | 3.1% | −414K | Jun 30, 2026 |
| Takeda Pharmaceutical Co. Ltd. TSE:4502 | 791K | US$25.3M | 2.9% | −343K | Jun 30, 2026 |
| Zoetis Inc. NYSE:ZTS | 257K | US$18.5M | 2.1% | −121K | Jun 30, 2026 |
| Viatris Inc. NASDAQ:VTRS | 606K | US$9.63M | 1.1% | −249K | Jun 30, 2026 |
| Jazz Pharmaceuticals plc NASDAQ:JAZZ | 39,436 | US$9.5M | 1.1% | −15,019 | Jun 30, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 27,589 | US$6.75M | 0.77% | −11,514 | Jun 30, 2026 |
| Corcept Therapeutics Incorporated NASDAQ:CORT | 50,964 | US$4.43M | 0.50% | −19,896 | Jun 30, 2026 |
| Elanco Animal Health Incorporated NYSE:ELAN | 126K | US$3.11M | 0.35% | −63,805 | Jun 30, 2026 |
| Organon & Co. NYSE:OGN | 149K | US$2.01M | 0.23% | −61,553 | Jun 30, 2026 |
| Bausch Health Companies Inc. TSX:BHC | 175K | US$861K | 0.10% | −72,461 | Jun 30, 2026 |
| Perrigo Company plc NYSE:PRGO | 50,862 | US$528K | 0.06% | −33,317 | Jun 30, 2026 |